Issue 16 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

31

No.

16

April 22, 2005Apr 22, 2005

Free

DOWNLOAD THE PDF

SWOG, NCI Canada halt two large trials of Iressa for non-small cell lung cancer.

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

Paulette Gray named director of NCI Division of Extramural Activities.

Recent Issues

Volume 52 | Issue 23 - June 12, 2026

Volume 52 | Issue 22 - June 05, 2026

Volume 52 | Issue 21 - May 29, 2026

Volume 52 | Issue 20 - May 22, 2026

Volume 52 | Issue 19 - May 15, 2026

Volume 52 | Issue 18 - May 08, 2026